 |
PDBsum entry 2g9v
|
|
|
|
References listed in PDB file
|
 |
|
Key reference
|
 |
|
Title
|
 |
Iminosugars as potential inhibitors of glycogenolysis: structural insights into the molecular basis of glycogen phosphorylase inhibition.
|
 |
|
Authors
|
 |
N.G.Oikonomakos,
C.Tiraidis,
D.D.Leonidas,
S.E.Zographos,
M.Kristiansen,
C.U.Jessen,
L.Nørskov-Lauritsen,
L.Agius.
|
 |
|
Ref.
|
 |
J Med Chem, 2006,
49,
5687-5701.
[DOI no: ]
|
 |
|
PubMed id
|
 |
|
 |
 |
|
Abstract
|
 |
|
Iminosugars DAB (5), isofagomine (9), and several N-substituted derivatives have
been identified as potent inhibitors of liver glycogen phosphorylase a (IC(50) =
0.4-1.2 microM) and of basal and glucagon-stimulated glycogenolysis (IC(50) =
1-3 microM). The X-ray structures of 5, 9, and its N-3-phenylpropyl analogue 8
in complex with rabbit muscle glycogen phosphorylase (GPb) shows that
iminosugars bind tightly at the catalytic site in the presence of the substrate
phosphate and induce conformational changes that characterize the R-state
conformation of the enzyme. Charged nitrogen N1 is within hydrogen-bonding
distance with the carbonyl oxygen of His377 (5) and in ionic contact with the
substrate phosphate oxygen (8 and 9). Our findings suggest that the inhibitors
function as oxocarbenium ion transition-state analogues. The conformational
change to the R state provides an explanation for previous findings that 5,
unlike inhibitors that favor the T state, promotes phosphorylation of GPb in
hepatocytes with sequential inactivation of glycogen synthase.
|
 |
|
|
|
|
 |